DNA fragmentation in some organs of rats and mice treated with cycasin

M. Cavanna, S. Parodi, M. Taningher, C. Bolognesi, L. Sciabà, G. Brambilla

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Cycasin (methylazoxymethanol-β-D-glucoside) is carcinogenic in several animal species. It produces a variety of malignant tumours, mainly in the liver of mice, and in the liver, kidney and large intestine in rats. It does not appear to be mutagenic in the Ames test, even in the presence of liver microsome fraction, and it is among those carcinogens (less than 10%) ranked as false negatives in this test. The ability of cycasin to damage in vivo liver, kidney, lung and colonic DNA of Wistar rats and C57BL/6 mice was investigated by means of alkaline elution technique. Oral single-dose administration of cycasin, in the range of 50-400 mg/kg body weight, produced in the rat a clearly evident dose-dependent DNA fragmentation in the liver, and less marked damage to DNA from kidney and colon mucosa. In mice, the same treatment produced dose-dependent DNA damage only in the liver. DNA repair up to 18 h appeared to be incomplete both in mice and rats. Methylazoxymethanol acetate is considered to be an active form of cycasin. While in vivo methylazoxymethanol acetate caused DNA damage, in vitro it appeared inactive and required metabolic activation, possibly consisting in its hydrolysis by esterase activity, to be able to cause DNA fragmentation.

Original languageEnglish
Pages (from-to)383-390
Number of pages8
JournalBritish Journal of Cancer
Volume39
Issue number4
DOIs
Publication statusPublished - 1979

Fingerprint

Cycasin
DNA Fragmentation
Methylazoxymethanol Acetate
Liver
DNA Damage
Kidney
Large Intestine
Glucosides
Liver Microsomes
Esterases
Inbred C57BL Mouse
DNA Repair
Carcinogens
Wistar Rats
Colon
Mucous Membrane
Hydrolysis
Body Weight
Lung
DNA

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Cavanna, M., Parodi, S., Taningher, M., Bolognesi, C., Sciabà, L., & Brambilla, G. (1979). DNA fragmentation in some organs of rats and mice treated with cycasin. British Journal of Cancer, 39(4), 383-390. https://doi.org/10.1038/bjc.1979.70

DNA fragmentation in some organs of rats and mice treated with cycasin. / Cavanna, M.; Parodi, S.; Taningher, M.; Bolognesi, C.; Sciabà, L.; Brambilla, G.

In: British Journal of Cancer, Vol. 39, No. 4, 1979, p. 383-390.

Research output: Contribution to journalArticle

Cavanna, M, Parodi, S, Taningher, M, Bolognesi, C, Sciabà, L & Brambilla, G 1979, 'DNA fragmentation in some organs of rats and mice treated with cycasin', British Journal of Cancer, vol. 39, no. 4, pp. 383-390. https://doi.org/10.1038/bjc.1979.70
Cavanna, M. ; Parodi, S. ; Taningher, M. ; Bolognesi, C. ; Sciabà, L. ; Brambilla, G. / DNA fragmentation in some organs of rats and mice treated with cycasin. In: British Journal of Cancer. 1979 ; Vol. 39, No. 4. pp. 383-390.
@article{384884eb8d8f40d7bf37f0eb5edf26e9,
title = "DNA fragmentation in some organs of rats and mice treated with cycasin",
abstract = "Cycasin (methylazoxymethanol-β-D-glucoside) is carcinogenic in several animal species. It produces a variety of malignant tumours, mainly in the liver of mice, and in the liver, kidney and large intestine in rats. It does not appear to be mutagenic in the Ames test, even in the presence of liver microsome fraction, and it is among those carcinogens (less than 10{\%}) ranked as false negatives in this test. The ability of cycasin to damage in vivo liver, kidney, lung and colonic DNA of Wistar rats and C57BL/6 mice was investigated by means of alkaline elution technique. Oral single-dose administration of cycasin, in the range of 50-400 mg/kg body weight, produced in the rat a clearly evident dose-dependent DNA fragmentation in the liver, and less marked damage to DNA from kidney and colon mucosa. In mice, the same treatment produced dose-dependent DNA damage only in the liver. DNA repair up to 18 h appeared to be incomplete both in mice and rats. Methylazoxymethanol acetate is considered to be an active form of cycasin. While in vivo methylazoxymethanol acetate caused DNA damage, in vitro it appeared inactive and required metabolic activation, possibly consisting in its hydrolysis by esterase activity, to be able to cause DNA fragmentation.",
author = "M. Cavanna and S. Parodi and M. Taningher and C. Bolognesi and L. Sciab{\`a} and G. Brambilla",
year = "1979",
doi = "10.1038/bjc.1979.70",
language = "English",
volume = "39",
pages = "383--390",
journal = "British Journal of Cancer",
issn = "0007-0920",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - DNA fragmentation in some organs of rats and mice treated with cycasin

AU - Cavanna, M.

AU - Parodi, S.

AU - Taningher, M.

AU - Bolognesi, C.

AU - Sciabà, L.

AU - Brambilla, G.

PY - 1979

Y1 - 1979

N2 - Cycasin (methylazoxymethanol-β-D-glucoside) is carcinogenic in several animal species. It produces a variety of malignant tumours, mainly in the liver of mice, and in the liver, kidney and large intestine in rats. It does not appear to be mutagenic in the Ames test, even in the presence of liver microsome fraction, and it is among those carcinogens (less than 10%) ranked as false negatives in this test. The ability of cycasin to damage in vivo liver, kidney, lung and colonic DNA of Wistar rats and C57BL/6 mice was investigated by means of alkaline elution technique. Oral single-dose administration of cycasin, in the range of 50-400 mg/kg body weight, produced in the rat a clearly evident dose-dependent DNA fragmentation in the liver, and less marked damage to DNA from kidney and colon mucosa. In mice, the same treatment produced dose-dependent DNA damage only in the liver. DNA repair up to 18 h appeared to be incomplete both in mice and rats. Methylazoxymethanol acetate is considered to be an active form of cycasin. While in vivo methylazoxymethanol acetate caused DNA damage, in vitro it appeared inactive and required metabolic activation, possibly consisting in its hydrolysis by esterase activity, to be able to cause DNA fragmentation.

AB - Cycasin (methylazoxymethanol-β-D-glucoside) is carcinogenic in several animal species. It produces a variety of malignant tumours, mainly in the liver of mice, and in the liver, kidney and large intestine in rats. It does not appear to be mutagenic in the Ames test, even in the presence of liver microsome fraction, and it is among those carcinogens (less than 10%) ranked as false negatives in this test. The ability of cycasin to damage in vivo liver, kidney, lung and colonic DNA of Wistar rats and C57BL/6 mice was investigated by means of alkaline elution technique. Oral single-dose administration of cycasin, in the range of 50-400 mg/kg body weight, produced in the rat a clearly evident dose-dependent DNA fragmentation in the liver, and less marked damage to DNA from kidney and colon mucosa. In mice, the same treatment produced dose-dependent DNA damage only in the liver. DNA repair up to 18 h appeared to be incomplete both in mice and rats. Methylazoxymethanol acetate is considered to be an active form of cycasin. While in vivo methylazoxymethanol acetate caused DNA damage, in vitro it appeared inactive and required metabolic activation, possibly consisting in its hydrolysis by esterase activity, to be able to cause DNA fragmentation.

UR - http://www.scopus.com/inward/record.url?scp=0018775459&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018775459&partnerID=8YFLogxK

U2 - 10.1038/bjc.1979.70

DO - 10.1038/bjc.1979.70

M3 - Article

C2 - 444396

AN - SCOPUS:0018775459

VL - 39

SP - 383

EP - 390

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - 4

ER -